The grant will support innovative research on lipid-based immunotherapies, which could help develop the next generation of universal immunotherapies.
Georgia Tech chemists are exploring the behavior of a complex protein associated with glaucoma — characterizing one of the largest amyloid-forming proteins to date.
A new study co-led by Anna (Anya) Ivanova highlights how human neuroscience is paving the way for AI innovation — and what AI can teach us about ourselves.
Researchers at Georgia Tech have teamed up with NASA and five peer institutions to teach dog-like robots to navigate craters of the Moon and other challenging planetary surfaces.
Through detailed auditory descriptions and immersive virtual environments, the Sonification Lab facilitates accessibility to the wonders of the universe for all, regardless of visual ability.
A team of Georgia Tech researchers is the first to study the relationship between fluctuations in attention and the brain network patterns within low-frequency 20-second cycles.
The team used a computational math theory to identify gene-gene interactions that may be good targets for treating basal-like cancers that are resistant to traditional hormone therapies.
Chris Rozell traveled to Washington, D.C. to share the impacts of the past decade of brain research funded by the NIH BRAIN Initiative with Congress — and share with local representatives how Georgia Tech is playing a key role in leading the charge.
Trammell Crow Company delivers first phase of Georgia Tech district devoted to advancing sciences that improve the human condition
Board of Regents' Distinctions honor the recipients for their outstanding contributions and excellence.